Pfizer Needs The Seagen Deal
by Stone Fox Capital
Contributor since 2008 / 40721 Followers
Contributor since 2008 / 40721 Followers
2 years ago
Summary: Pfizer Inc. has been reported as bidding for Seagen Inc., competing with Merck &
Month: February 2023
Bank of America Lagging As The Street Prices In Some Odd Developments
by Stephen Simpson
Contributor since 2011 / 18584 Followers
Contributor since 2011 / 18584 Followers
2 years ago
Summary: Bank of America has lagged since earnings, with above-average rate sensitivity seen as a
Google Is The Most-Hated Tech Stock On Wall Street – Time To Buy
by Logan Kane
Contributor since 2018 / 20722 Followers
Contributor since 2018 / 20722 Followers
2 years ago
Summary: Google initially got swept up in the late-year AI minibubble, but now investors have
Agilysys: Strong Market Rally, But Poor Financials Make This A Hold
by Pratik Shinde
Contributor since 2023 / 31 Followers
Contributor since 2023 / 31 Followers
2 years ago
Summary: Agilysys is a leading software company that provides technology solutions for the hospitality industry.
Disney: Changes Signal Sharper Focus On Profitability, Upgrade To Buy
by Intrinsic Analysis
Contributor since 2020 / 279 Followers
Contributor since 2020 / 279 Followers
2 years ago
Summary: Returning CEO Bob Iger announced a cost reduction program and an organizational restructure that
Rivian: Fear Is In The Air
by JR Research
Contributor since 2021 / 22018 Followers
Contributor since 2021 / 22018 Followers
2 years ago
Summary: Despite a remarkable 45% rebound, RIVN’s January gains have largely dissipated as shrewd sellers
Pfizer-Seagen: Dividend Risk Evaluation
by Tradevestor
Contributor since 2012 / 5495 Followers
Contributor since 2012 / 5495 Followers
2 years ago
Summary: Does the rumored Seagen Inc. deal jeopardize Pfizer Inc.’s ability to pay dividends to
Tesla Is Running Low In Power (Technical Analysis)
by Mirco Lysek
Contributor since 2022 / 1735 Followers
Contributor since 2022 / 1735 Followers
2 years ago
Summary: TSLA has formed a massive 114% short-term rally which is now giving signs of
UnitedHealth Group: The Market Is Underpricing This Unique Health Care Operator
by Yuval Rotem
Contributor since 2023 / 42 Followers
Contributor since 2023 / 42 Followers
2 years ago
Summary: UnitedHealth Group is trading below its 5-Yr average P/E ratio. The stock went down
3M: This Is What A Bargain Looks Like
by Hoya Capital
Contributor since 2015 / 32400 Followers
Contributor since 2015 / 32400 Followers
2 years ago
Summary: 3M is now trading at a very low valuation and pays a historically high